How Much Does Jardiance Cost?

Published on January 16, 2026 | Prices Last Reviewed for Freshness: February 2026
Written by Alec Pow - Economic & Pricing Investigator | Medical Review by Sarah Nguyen, MD

Educational content; not medical advice. Prices are typical estimates and may exclude insurance benefits; confirm with a licensed clinician and your insurer.

Jardiance is the brand name for empagliflozin, an SGLT2 inhibitor used in adults with type 2 diabetes, chronic kidney disease and heart failure, often alongside diet and exercise. It improves blood sugar control and has cardiovascular and kidney benefits, which makes it a long term therapy for many patients.

Cash prices at retail pharmacies in the United States can reach hundreds of dollars per month, according to the Drugs.com price guide, while insured patients, Medicare users and people who qualify for savings programs often pay far less.

This guide looks at current Jardiance price bands in 2025, explains how list prices differ from real out of pocket costs, compares pharmacies and discount platforms such as the GoodRx Jardiance cost guide, and walks through concrete ways to cut the bill without interrupting treatment.

How Much Does Jardiance Cost?

For patients paying the retail rate at a U.S. brick and mortar pharmacy, a typical 30 day supply of Jardiance 10 mg or 25 mg is often listed between $600 and $900, although some national price guides and patient advocacy sites like The Rx Advocates show average tags in the mid $700 range as of late 2025.

Discounted cash prices can drop sharply once a patient uses a coupon or savings card. GoodRx reports an average retail price around $750+ for 30 tablets of 10 mg Jardiance, but coupons can lower that to the mid $300 range at some pharmacies.

Insured patients usually see a very different bill. Boehringer Ingelheim, the manufacturer, states that about 94 percent of commercially insured patients pay between $0 and $50 per month for Jardiance, while a smaller group pays an average of around $230 per month.

Medicare Part D users often fall into a middle band. An analysis from SingleCare estimates that most people with a Part D plan pay about $50 a month for Jardiance, subject to the deductible and coverage stage, and a Kiplinger Medicare cost guide notes that starting in 2025 their annual Part D out of pocket drug spending is capped at $2,000.

Dose strength has less effect on price than many people expect, since cash prices for 10 mg and 25 mg tablets tend to be similar for the same quantity. The bigger swing usually comes from supply length, with 90 day refills often priced higher in total but lower per tablet.

Real-Life Cost Examples

Price comparison tools illustrate how wide the spread can be between pharmacies. One PharmacyChecker analysis showed U.S. average retail prices around $618 to $624 for 30 tablets of Jardiance in the 10 mg and 25 mg strengths, with U.S. discount card pricing closer to $518.

At big box and chain locations, list prices often cluster in similar bands. Public examples for a 30 day 25 mg supply include cash prices in the $800+ range at some pharmacies, then coupon adjusted figures around $250 to $350, based on pricing shown by SingleCare and GoodRx at selected stores.

You might also like our articles about the cost of Ozempic, Mounjaro, or Retratrutide.

Discount platforms that partner with specific stores show additional nuance. One RxConnected roundup listed GoodRx offers near $580 for 10 mg, 30 tablets through selected Rite Aid locations, while international online pharmacies accredited by PharmacyChecker advertised per tablet prices near $1.26 for larger 25 mg orders, which helps explain why some patients explore cross border mail order options even when import rules are complex.

A patient in Ohio paying cash at a neighborhood chain might see a till receipt near $850 for 30 tablets, then shave that down to roughly $280 after applying a widely available coupon. Someone with a high deductible employer plan in Texas may spend around $40 per month after hitting the deductible, while a Medicare user in Florida commonly reports a copay near $45 once their Part D coverage stage stabilizes. These examples illustrate how the same drug can carry very different real world bills, entirely due to plan design and coupon use.

Cost Breakdown

For most people, the starting point is the retail list price that pharmacies post for Jardiance. That rack rate is shaped by the wholesale acquisition cost, pharmacy markups and negotiated discounts, but the important detail for patients is that nearly no one actually pays list if they have coverage or a savings option.

Once insurance is active, the cost shifts into a copay or coinsurance structure based on formulary tier, preferred pharmacy networks and whether a deductible still applies. Many commercial plans place Jardiance on a preferred brand tier with flat copays, while others use percentage based coinsurance that exposes patients to more of the drug’s price when they have not yet met the deductible.

Manufacturer support then creates a second layer. The Jardiance Savings Card can drop eligible commercially insured patients to as little as $0 to $10 per prescription with a monthly savings cap, and the company also operates a separate patient assistance program that may provide the drug at no cost for certain low income or uninsured patients, with details spelled out in the official savings card terms.

Pharmacy benefit managers sit behind much of this structure. They negotiate rebates and price concessions that influence where Jardiance lands on the formulary and which pharmacies are preferred. Patients rarely see these contracts, but the impact shows up in copay tiers, required prior authorization, or step therapy that steers them toward alternative diabetes medication before Jardiance is approved.

Factors Influencing the Cost

Plan design is usually the single biggest driver of how much a patient pays per refill. A subsidized employer PPO with a low deductible behaves very differently from a bronze tier marketplace plan with a high deductible or a Medicare Advantage plan with a narrow network, and the Medicare cost basics page shows the same pattern across federal plans.

Deductibles and out of pocket maximums reshape the bill across the year. Early in the plan year, patients may pay the full contracted price until the deductible is reached, then settle into lower copays during the standard coverage phase, followed by reduced amounts once any out of pocket caps or the newer Medicare Part D protections kick in.

Brand status also matters. The U.S. Food and Drug Administration has not approved a fully interchangeable generic version of Jardiance as of early 2026, so there is no true low cost generic empagliflozin on the U.S. market yet, even though unbranded versions exist in other countries according to the empagliflozin versus Jardiance comparison on Drugs.com and the empagliflozin entry on Wikipedia.

Where a prescription is filled can create further variation. Independent pharmacies, supermarket chains, warehouse clubs and accredited international mail order services may each post distinct prices and discount structures, which allows motivated patients to shop their prescription across several outlets before settling on a long term supplier.

Alternative Products or Services

Jardiance sits within the SGLT2 inhibitor class, so alternatives often include Farxiga, Invokana and other related drugs that lower blood glucose and support heart and kidney health. The American Diabetes Association Standards of Care highlight SGLT2 inhibitors in general as important options for people with type 2 diabetes and cardiovascular or kidney disease, and a recent review in PubMed indexed literature reinforces those benefits.

Cash prices for these alternatives usually fall in similar bands, but individual formularies sometimes place one competitor on a lower tier, which can cut patient copays materially. Many people combine an SGLT2 inhibitor with metformin, GLP 1 agonists or insulin, and some fixed dose combination pills are available that bundle agents into one prescription even though their monthly cost may be higher than metformin alone, as outlined in the SGLT2 inhibitor overview and on GoodRx.

Lifestyle strategies such as nutrition counseling, physical activity programs and weight loss interventions carry their own expenses, but they can reduce the need for additional diabetes medications over time, which changes the long term drug bill. That is one reason guidelines push for dietary and exercise changes alongside pharmacologic treatment, not as replacements but as complementary tools that support lower doses and fewer complications.

Ways to Spend Less

The most direct lever for many people with commercial insurance is the Jardiance Savings Card. Eligible patients can register through the manufacturer site’s Jardiance savings page and may pay as little as $0 to $10 per month for a 30 to 90 day prescription, with maximum savings amounts per fill detailed in the linked One Card Savings program.

People who do not qualify for manufacturer savings, or who prefer a simpler card, can often reduce costs with third party coupons. GoodRx, SingleCare and similar services provide free discount cards and digital coupons that can bring a typical Jardiance refill down from the $700+ range to around $250 to $350, depending on pharmacy and quantity.

Prescribers can also help by writing 90 day supplies when clinically appropriate. Many plans structure benefits so that a 90 day mail order or preferred pharmacy fill carries a slightly lower per tablet charge, even if the upfront bill looks larger. For people on stable long term dosing, this reduces both annual spending and the number of pharmacy visits.

In a typical worked example, a patient with a high deductible plan might see a January bill of around $800 for Jardiance before the deductible is met. After applying a coupon, that first fill could drop to about $280. Once the deductible is satisfied later in the year, manufacturer copay support might reduce each refill to roughly $25. Across twelve months, their total spend might land near $555 in copays plus the upfront discounted fill, instead of more than $9,000 at raw retail pricing.

Expert Insights & Tips

Guidelines from the American Diabetes Association describe SGLT2 inhibitors as key medications for many people with type 2 diabetes who have cardiovascular disease, heart failure or chronic kidney disease, which means doctors weigh both clinical outcomes and financial impact when they select a specific drug such as Jardiance.

Endocrinology and primary care teams often encourage patients to bring their pharmacy printouts to visits so that the clinician can see actual copays, not just list prices. Pharmacists add another layer by flagging when a plan places Jardiance on a nonpreferred tier, then suggesting formulary alternatives, savings cards or mail order options that reduce the line item on the bill without sacrificing control of blood sugar, a pattern described in a PowerPak CE overview of the ADA standards.

Case stories underline the value of asking about cost. One patient in California moved from paying around $90 per month to under $10 after a care manager helped enroll them in a manufacturer savings program. Another in New York shifted their prescription to a preferred 90 day mail order pharmacy, which cut their annual Jardiance expenses by several hundred dollars compared with monthly local refills.

Total Cost of Ownership

Because Jardiance is part of chronic disease management, the yearly expense is often a more useful mental model than the sticker on a single box. A person paying the average Medicare Part D copay of around $50 per month, for example, faces roughly $600 per year in direct Jardiance costs, not including premiums, lab work or office visits related to diabetes and heart or kidney monitoring.

An uninsured patient paying near the top of the $600 to $900 monthly retail band could face annual expenses between roughly $7,200 and $10,800 if no coupons or assistance are applied. That starts to resemble a small car payment, especially when layered on costs for insulin, GLP 1 agonists or blood pressure medication that often sit beside Jardiance on a chronic medication list.

For people using savings strategies effectively, the numbers shift down. Someone who qualifies for $10 manufacturer supported copays for nine months of the year and pays a higher amount during deductible months may see total annual Jardiance spending closer to the $150 to $300 range, which is still meaningful but substantially lighter than full retail. Over a five year horizon that difference can approach tens of thousands of dollars, especially for patients who combine Jardiance with several other brand name drugs.

Hidden & Unexpected Costs

The pill bottle is not the only line on the ledger. Periodic lab tests to monitor kidney function, electrolytes and blood sugar control, such as A1C and basic metabolic panels, bring their own charges, which might run from $20 to $150 per draw depending on insurance and lab contracts, as summarized in a NursingCenter guideline summary.

Specialist visits with endocrinologists or cardiologists add copays, often in the $30 to $60 range for many commercial plans and higher for some high deductible designs. In addition, denied prior authorizations or step therapy requirements can result in periods where patients pay for interim medications or more frequent office visits while paperwork is resolved, which adds indirect cost even when the drug itself is eventually covered.

Some people also buy glucose meters, continuous glucose monitors, and supplies such as lancets or test strips. These purchases can quietly add several hundred dollars per year to the total cost of managing diabetes, especially for those whose plans have separate durable medical equipment cost sharing rules that differ from pharmacy benefits.

Medicare & Medicaid Costs

For Medicare beneficiaries, Jardiance is typically covered under Part D or Medicare Advantage prescription drug plans, often as a preferred brand on the formulary. Current summaries suggest that most Part D users pay about $50 per month, although exact figures vary by plan, region and phase of coverage.

From 2025 onward, the Inflation Reduction Act introduces a $2,000 annual cap on out of pocket Part D drug costs, including cardiometabolic medications such as Jardiance, and the Centers for Medicare & Medicaid Services fact sheet explains how these negotiated prices roll out through 2026.

Medicaid coverage is more fragmented and handled state by state through preferred drug lists and managed care contracts. Many programs list Jardiance or another SGLT2 inhibitor as a covered option for type 2 diabetes and heart failure, but prior authorization and step therapy requirements are common, so copays may be low while access hurdles remain, as described in an AARP drug price policy brief.

Resale Value & Depreciation

Brand name drugs lose financial weight once generics arrive, even if the clinical profile stays constant. Empagliflozin already has lower priced generic competitors in countries such as India, where a 25 mg tablet of a local brand can cost a fraction of the branded Jardiance product, according to Indian price listings, which hints at the price direction once true generics arrive in the United States.

When generic empagliflozin becomes widely available in U.S. pharmacies, early year discounts may still be modest as manufacturers recoup launch costs, then prices usually fall over several years as more companies enter the market. Brand loyalty sometimes keeps a subset of patients on Jardiance, but long horizon budget planning for chronic conditions often assumes a move to generic once prescribers and payers are comfortable with alternatives.

Answers to Common Questions

Below are brief answers to common search questions about Jardiance pricing today, drawing on the data and examples covered above.

What is the cheapest way to get Jardiance in 2026?

For people with commercial insurance, the lowest monthly bills often come from combining a formulary preferred status with the Jardiance Savings Card, which can reduce copays to between $0 and $10 per month when eligibility criteria are met. Those without access to this program may get the best price through a reputable coupon service at a competitive local or mail order pharmacy.

Does insurance cover Jardiance?

Many employer and marketplace plans cover Jardiance as a brand name diabetes medication, although copays and prior authorization rules vary. Medicare Part D and Medicare Advantage plans also list Jardiance on their formularies, with average copays near $50 per month, while Medicaid coverage is determined by each state’s preferred drug list and utilization management rules.

Is there a generic version of Jardiance available?

As of early 2026, the U.S. Food and Drug Administration has not approved a fully interchangeable generic empagliflozin that replaces Jardiance at American pharmacies, although unbranded versions exist in markets such as India. U.S. patients still pay brand level prices, which underpins the value of savings programs and coupons for now.

How much does Jardiance cost at Walmart or Costco?

Cash prices at large retailers typically fall within the $600 to $900 range for a 30 day supply, similar to other chain pharmacies, but using a coupon can reduce that considerably, sometimes into the $250 to $350 band. Exact figures change by location and over time, so checking a real time price comparison tool before each refill is sensible.

Can patients legally import Jardiance from Canada?

U.S. regulators generally allow individuals to import small quantities of certain medications for personal use under specific conditions, but the rules are narrow and complex. Accredited international mail order pharmacies can offer lower prices on empagliflozin, yet patients should review Food and Drug Administration guidance and consult their clinician and insurer before relying on cross border supply.